Your Search Results

Haemodynamic support: from shock to complex high-risk interventional problems

21 May 2026 – From EuroPCR 2026

This session examines haemodynamic support from cardiogenic shock through to complex high-risk interventional cardiology procedures. It features registry data, clinical outcomes, and procedural techniques including mechanical circulatory support and arterial access strategies.

Challenging clinical scenarios in STEMI

21 May 2026 – From EuroPCR 2026

This session explores challenging clinical scenarios in STEMI, including coronary embolisation from aortic valve vegetation, blunt chest trauma-related STEMI, intramural hematoma diagnostics with multimodality imaging, acute stent thrombosis during dengue recovery, and advanced clot removal techniques beyond standard aspiration devices.

TAVI in heart failure is possible

21 May 2026 – From EuroPCR 2026

This session demonstrates the feasibility of transcatheter aortic valve implantation (TAVI) in patients with heart failure through a series of challenging cases. It covers sequential management of hypertrophic obstructive cardiomyopathy with aortic stenosis, advanced heart failure interventions, staged approaches in cardiogenic shock, and complex percutaneous interventions...

The pearl of unloading with mechanical circulatory support

21 May 2026 – From EuroPCR 2026

Delve into the critical aspects of mechanical circulatory support in cardiogenic shock, focusing on device selection, assessment of persistent congestion, and the application of unloading tools to improve patient management and outcomes.

The pearl of unloading with mechanical circulatory support

ACST-2 (Second asymptomatic carotid surgery trial): stenting vs. surgery for tight carotid stenosis

26 Aug 2021

Ali Nazmi Calik and Pascal Meier review this trial comparing CEA with CAS for patients with asymptomatic carotid stenosis, which was presented by Alison Halliday (Oxford, United Kingdom of Great Britain & Northern Ireland) during a Hot Line session of the ESC Congress 2021.